GC Wealth Management RIA LLC Has $5.28 Million Stake in McKesson Corporation $MCK

GC Wealth Management RIA LLC trimmed its position in shares of McKesson Corporation (NYSE:MCK) by 15.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,433 shares of the company’s stock after selling 1,135 shares during the period. GC Wealth Management RIA LLC’s holdings in McKesson were worth $5,277,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in MCK. Brighton Jones LLC boosted its stake in shares of McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP acquired a new stake in McKesson during the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC boosted its position in McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after buying an additional 300 shares during the period. Treasurer of the State of North Carolina increased its position in McKesson by 0.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock valued at $42,958,000 after purchasing an additional 508 shares during the period. Finally, Osterweis Capital Management Inc. bought a new position in McKesson during the 2nd quarter worth approximately $166,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Trading Up 0.8%

Shares of NYSE MCK opened at $834.55 on Wednesday. The stock has a fifty day simple moving average of $899.76 and a two-hundred day simple moving average of $859.72. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The firm has a market cap of $102.22 billion, a price-to-earnings ratio of 24.00, a price-to-earnings-growth ratio of 1.20 and a beta of 0.42.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. During the same quarter last year, the company earned $8.03 earnings per share. The company’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts forecast that McKesson Corporation will post 39.02 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s payout ratio is currently 9.43%.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Leerink Partners restated an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. William Blair started coverage on shares of McKesson in a research note on Tuesday. They set an “outperform” rating for the company. JPMorgan Chase & Co. boosted their price target on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Finally, UBS Group decreased their price target on shares of McKesson from $1,012.00 to $1,000.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $972.27.

Insider Buying and Selling at McKesson

In other news, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares in the company, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michele Lau sold 2,725 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,592 shares of company stock valued at $3,518,555 over the last 90 days. 0.08% of the stock is currently owned by corporate insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.